Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1775 Plus Carboplatin-Paclitaxel in Squamous Cell Lung Cancer
NCT02513563Phase 2Completed
- Sponsor
- Moffitt Cancer Center
- Start
- Oct 2015
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of adavosertib in squamous cell carcinoma of the lung (LSCC), sponsored by Moffitt Cancer Center. Started Oct 2015; status: completed.
02
Drugs
adavosertib
03
Conditions
squamous cell carcinoma of the lung (LSCC)
Beyond the preview
Go deeper on NCT02513563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02513563.